The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Molecular Diagnostic Products Market Research Report 2025
Synopsis
Molecular Diagnostic Products are medical tools and tests that identify and analyze genetic and molecular markers in biological samples. These products enable the detection of specific DNA, RNA, or protein sequences associated with diseases or conditions. Molecular diagnostic products are used in fields such as genetics, oncology, infectious diseases, and personalized medicine.
The global Molecular Diagnostic Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Products.
Report Scope
The Molecular Diagnostic Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostic Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostic Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
ThermoFisher
Roche
DAAN Gene
BGI Group
Agilent Technologies
QIAGEN
Macrogen
ELITech Group
Analytik Jena
Bio-Rad
Promega
Texas BioGene
Segment by Type
Molecular Diagnostic Reagents
Molecular Diagnostic Instruments
Segment by Application
Clinics
Hospitals
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostic Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Molecular Diagnostic Products are medical tools and tests that identify and analyze genetic and molecular markers in biological samples. These products enable the detection of specific DNA, RNA, or protein sequences associated with diseases or conditions. Molecular diagnostic products are used in fields such as genetics, oncology, infectious diseases, and personalized medicine.
The global Molecular Diagnostic Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Products.
Report Scope
The Molecular Diagnostic Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostic Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostic Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
ThermoFisher
Roche
DAAN Gene
BGI Group
Agilent Technologies
QIAGEN
Macrogen
ELITech Group
Analytik Jena
Bio-Rad
Promega
Texas BioGene
Segment by Type
Molecular Diagnostic Reagents
Molecular Diagnostic Instruments
Segment by Application
Clinics
Hospitals
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostic Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostic Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Molecular Diagnostic Reagents
1.2.3 Molecular Diagnostic Instruments
1.3 Market by Application
1.3.1 Global Molecular Diagnostic Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostic Products Market Perspective (2019-2030)
2.2 Molecular Diagnostic Products Growth Trends by Region
2.2.1 Global Molecular Diagnostic Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Diagnostic Products Historic Market Size by Region (2019-2024)
2.2.3 Molecular Diagnostic Products Forecasted Market Size by Region (2025-2030)
2.3 Molecular Diagnostic Products Market Dynamics
2.3.1 Molecular Diagnostic Products Industry Trends
2.3.2 Molecular Diagnostic Products Market Drivers
2.3.3 Molecular Diagnostic Products Market Challenges
2.3.4 Molecular Diagnostic Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostic Products Players by Revenue
3.1.1 Global Top Molecular Diagnostic Products Players by Revenue (2019-2024)
3.1.2 Global Molecular Diagnostic Products Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostic Products Revenue
3.4 Global Molecular Diagnostic Products Market Concentration Ratio
3.4.1 Global Molecular Diagnostic Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostic Products Revenue in 2023
3.5 Molecular Diagnostic Products Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostic Products Product Solution and Service
3.7 Date of Enter into Molecular Diagnostic Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostic Products Breakdown Data by Type
4.1 Global Molecular Diagnostic Products Historic Market Size by Type (2019-2024)
4.2 Global Molecular Diagnostic Products Forecasted Market Size by Type (2025-2030)
5 Molecular Diagnostic Products Breakdown Data by Application
5.1 Global Molecular Diagnostic Products Historic Market Size by Application (2019-2024)
5.2 Global Molecular Diagnostic Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Diagnostic Products Market Size (2019-2030)
6.2 North America Molecular Diagnostic Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Diagnostic Products Market Size by Country (2019-2024)
6.4 North America Molecular Diagnostic Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostic Products Market Size (2019-2030)
7.2 Europe Molecular Diagnostic Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Diagnostic Products Market Size by Country (2019-2024)
7.4 Europe Molecular Diagnostic Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostic Products Market Size (2019-2030)
8.2 Asia-Pacific Molecular Diagnostic Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Diagnostic Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Diagnostic Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostic Products Market Size (2019-2030)
9.2 Latin America Molecular Diagnostic Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Diagnostic Products Market Size by Country (2019-2024)
9.4 Latin America Molecular Diagnostic Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostic Products Market Size (2019-2030)
10.2 Middle East & Africa Molecular Diagnostic Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Diagnostic Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Diagnostic Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Molecular Diagnostic Products Introduction
11.1.4 Illumina Revenue in Molecular Diagnostic Products Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 ThermoFisher
11.2.1 ThermoFisher Company Detail
11.2.2 ThermoFisher Business Overview
11.2.3 ThermoFisher Molecular Diagnostic Products Introduction
11.2.4 ThermoFisher Revenue in Molecular Diagnostic Products Business (2019-2024)
11.2.5 ThermoFisher Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Molecular Diagnostic Products Introduction
11.3.4 Roche Revenue in Molecular Diagnostic Products Business (2019-2024)
11.3.5 Roche Recent Development
11.4 DAAN Gene
11.4.1 DAAN Gene Company Detail
11.4.2 DAAN Gene Business Overview
11.4.3 DAAN Gene Molecular Diagnostic Products Introduction
11.4.4 DAAN Gene Revenue in Molecular Diagnostic Products Business (2019-2024)
11.4.5 DAAN Gene Recent Development
11.5 BGI Group
11.5.1 BGI Group Company Detail
11.5.2 BGI Group Business Overview
11.5.3 BGI Group Molecular Diagnostic Products Introduction
11.5.4 BGI Group Revenue in Molecular Diagnostic Products Business (2019-2024)
11.5.5 BGI Group Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Molecular Diagnostic Products Introduction
11.6.4 Agilent Technologies Revenue in Molecular Diagnostic Products Business (2019-2024)
11.6.5 Agilent Technologies Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Molecular Diagnostic Products Introduction
11.7.4 QIAGEN Revenue in Molecular Diagnostic Products Business (2019-2024)
11.7.5 QIAGEN Recent Development
11.8 Macrogen
11.8.1 Macrogen Company Detail
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Molecular Diagnostic Products Introduction
11.8.4 Macrogen Revenue in Molecular Diagnostic Products Business (2019-2024)
11.8.5 Macrogen Recent Development
11.9 ELITech Group
11.9.1 ELITech Group Company Detail
11.9.2 ELITech Group Business Overview
11.9.3 ELITech Group Molecular Diagnostic Products Introduction
11.9.4 ELITech Group Revenue in Molecular Diagnostic Products Business (2019-2024)
11.9.5 ELITech Group Recent Development
11.10 Analytik Jena
11.10.1 Analytik Jena Company Detail
11.10.2 Analytik Jena Business Overview
11.10.3 Analytik Jena Molecular Diagnostic Products Introduction
11.10.4 Analytik Jena Revenue in Molecular Diagnostic Products Business (2019-2024)
11.10.5 Analytik Jena Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Detail
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad Molecular Diagnostic Products Introduction
11.11.4 Bio-Rad Revenue in Molecular Diagnostic Products Business (2019-2024)
11.11.5 Bio-Rad Recent Development
11.12 Promega
11.12.1 Promega Company Detail
11.12.2 Promega Business Overview
11.12.3 Promega Molecular Diagnostic Products Introduction
11.12.4 Promega Revenue in Molecular Diagnostic Products Business (2019-2024)
11.12.5 Promega Recent Development
11.13 Texas BioGene
11.13.1 Texas BioGene Company Detail
11.13.2 Texas BioGene Business Overview
11.13.3 Texas BioGene Molecular Diagnostic Products Introduction
11.13.4 Texas BioGene Revenue in Molecular Diagnostic Products Business (2019-2024)
11.13.5 Texas BioGene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Molecular Diagnostic Products Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Molecular Diagnostic Reagents
Table 3. Key Players of Molecular Diagnostic Instruments
Table 4. Global Molecular Diagnostic Products Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Molecular Diagnostic Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Molecular Diagnostic Products Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Molecular Diagnostic Products Market Share by Region (2019-2024)
Table 8. Global Molecular Diagnostic Products Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Molecular Diagnostic Products Market Share by Region (2025-2030)
Table 10. Molecular Diagnostic Products Market Trends
Table 11. Molecular Diagnostic Products Market Drivers
Table 12. Molecular Diagnostic Products Market Challenges
Table 13. Molecular Diagnostic Products Market Restraints
Table 14. Global Molecular Diagnostic Products Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Molecular Diagnostic Products Market Share by Players (2019-2024)
Table 16. Global Top Molecular Diagnostic Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostic Products as of 2023)
Table 17. Ranking of Global Top Molecular Diagnostic Products Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Molecular Diagnostic Products Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Molecular Diagnostic Products Product Solution and Service
Table 21. Date of Enter into Molecular Diagnostic Products Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Molecular Diagnostic Products Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Molecular Diagnostic Products Revenue Market Share by Type (2019-2024)
Table 25. Global Molecular Diagnostic Products Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Molecular Diagnostic Products Revenue Market Share by Type (2025-2030)
Table 27. Global Molecular Diagnostic Products Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Molecular Diagnostic Products Revenue Market Share by Application (2019-2024)
Table 29. Global Molecular Diagnostic Products Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Molecular Diagnostic Products Revenue Market Share by Application (2025-2030)
Table 31. North America Molecular Diagnostic Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Molecular Diagnostic Products Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Molecular Diagnostic Products Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Molecular Diagnostic Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Molecular Diagnostic Products Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Molecular Diagnostic Products Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Molecular Diagnostic Products Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Molecular Diagnostic Products Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnostic Products Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Molecular Diagnostic Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Molecular Diagnostic Products Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Molecular Diagnostic Products Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Molecular Diagnostic Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Molecular Diagnostic Products Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnostic Products Market Size by Country (2025-2030) & (US$ Million)
Table 46. Illumina Company Detail
Table 47. Illumina Business Overview
Table 48. Illumina Molecular Diagnostic Products Product
Table 49. Illumina Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 50. Illumina Recent Development
Table 51. ThermoFisher Company Detail
Table 52. ThermoFisher Business Overview
Table 53. ThermoFisher Molecular Diagnostic Products Product
Table 54. ThermoFisher Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 55. ThermoFisher Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Molecular Diagnostic Products Product
Table 59. Roche Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. DAAN Gene Company Detail
Table 62. DAAN Gene Business Overview
Table 63. DAAN Gene Molecular Diagnostic Products Product
Table 64. DAAN Gene Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 65. DAAN Gene Recent Development
Table 66. BGI Group Company Detail
Table 67. BGI Group Business Overview
Table 68. BGI Group Molecular Diagnostic Products Product
Table 69. BGI Group Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 70. BGI Group Recent Development
Table 71. Agilent Technologies Company Detail
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Molecular Diagnostic Products Product
Table 74. Agilent Technologies Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 75. Agilent Technologies Recent Development
Table 76. QIAGEN Company Detail
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Molecular Diagnostic Products Product
Table 79. QIAGEN Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 80. QIAGEN Recent Development
Table 81. Macrogen Company Detail
Table 82. Macrogen Business Overview
Table 83. Macrogen Molecular Diagnostic Products Product
Table 84. Macrogen Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 85. Macrogen Recent Development
Table 86. ELITech Group Company Detail
Table 87. ELITech Group Business Overview
Table 88. ELITech Group Molecular Diagnostic Products Product
Table 89. ELITech Group Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 90. ELITech Group Recent Development
Table 91. Analytik Jena Company Detail
Table 92. Analytik Jena Business Overview
Table 93. Analytik Jena Molecular Diagnostic Products Product
Table 94. Analytik Jena Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 95. Analytik Jena Recent Development
Table 96. Bio-Rad Company Detail
Table 97. Bio-Rad Business Overview
Table 98. Bio-Rad Molecular Diagnostic Products Product
Table 99. Bio-Rad Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 100. Bio-Rad Recent Development
Table 101. Promega Company Detail
Table 102. Promega Business Overview
Table 103. Promega Molecular Diagnostic Products Product
Table 104. Promega Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 105. Promega Recent Development
Table 106. Texas BioGene Company Detail
Table 107. Texas BioGene Business Overview
Table 108. Texas BioGene Molecular Diagnostic Products Product
Table 109. Texas BioGene Revenue in Molecular Diagnostic Products Business (2019-2024) & (US$ Million)
Table 110. Texas BioGene Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostic Products Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Molecular Diagnostic Products Market Share by Type: 2023 VS 2030
Figure 3. Molecular Diagnostic Reagents Features
Figure 4. Molecular Diagnostic Instruments Features
Figure 5. Global Molecular Diagnostic Products Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Molecular Diagnostic Products Market Share by Application: 2023 VS 2030
Figure 7. Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Laboratory Case Studies
Figure 10. Others Case Studies
Figure 11. Molecular Diagnostic Products Report Years Considered
Figure 12. Global Molecular Diagnostic Products Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Molecular Diagnostic Products Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Molecular Diagnostic Products Market Share by Region: 2023 VS 2030
Figure 15. Global Molecular Diagnostic Products Market Share by Players in 2023
Figure 16. Global Top Molecular Diagnostic Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostic Products as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnostic Products Revenue in 2023
Figure 18. North America Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Molecular Diagnostic Products Market Share by Country (2019-2030)
Figure 20. United States Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Molecular Diagnostic Products Market Share by Country (2019-2030)
Figure 24. Germany Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Molecular Diagnostic Products Market Share by Region (2019-2030)
Figure 32. China Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Molecular Diagnostic Products Market Share by Country (2019-2030)
Figure 40. Mexico Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Molecular Diagnostic Products Market Share by Country (2019-2030)
Figure 44. Turkey Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Molecular Diagnostic Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Illumina Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 47. ThermoFisher Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 48. Roche Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 49. DAAN Gene Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 50. BGI Group Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 51. Agilent Technologies Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 52. QIAGEN Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 53. Macrogen Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 54. ELITech Group Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 55. Analytik Jena Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 56. Bio-Rad Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 57. Promega Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 58. Texas BioGene Revenue Growth Rate in Molecular Diagnostic Products Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
